Showing results (201-210 of 444) with videos related to

Sort By:
Pageof 45
Chest|March 1, 2014
Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic reviewTiffany A Winstone, Deborah Assayag, Pearce G Wilcox, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2004
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposureLuca Richeldi, Katie Ewer, Monica Losi, et al.
The Cochrane Database of Systematic Reviews|September 9, 2010
Non-steroid agents for idiopathic pulmonary fibrosisPaolo Spagnolo, Cinzia Del Giovane, Fabrizio Luppi, et al.
Chest|December 12, 2018
Idiopathic Pulmonary Fibrosis: Prospective, Case-Controlled Study of Natural History and Circulating BiomarkersGanesh Raghu, Luca Richeldi, Alexandre Jagerschmidt, et al.
BMJ Open Respiratory Research|June 11, 2019
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trialsLisa Lancaster, Bruno Crestani, Paul Hernandez, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 17, 2025
High-flow nasal cannula in severe asthma exacerbations: current evidence and clinical perspectivesLorenzo Carriera, Simone Ielo, Roberto Barone, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2007
Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?Brent W Kinder, Harold R Collard, Laura Koth, et al.
Respiratory Medicine|December 17, 2013
Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: a prospective cohort studyChristopher J Ryerson, Cindy Cayou, Fiona Topp, et al.
Respiratory Medicine|May 16, 2017
Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung diseaseJake G Natalini, Jeff J Swigris, Julie Morisset, et al.
ERJ Open Research|October 27, 2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceSophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, et al.
Pageof 45